# Safety and Efficacy Study of EXC 001 to Improve the Appearance of Scars in Subjects Undergoing Elective Abdominoplasty

> **NCT01037985** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 41 (actual)

## Conditions studied

- Scar Prevention

## Interventions

- **DRUG:** EXC 001
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01037985
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12-03
- **Primary completion:** 2010-07-07
- **Final completion:** 2010-09-22
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2021-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01037985

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01037985, "Safety and Efficacy Study of EXC 001 to Improve the Appearance of Scars in Subjects Undergoing Elective Abdominoplasty". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT01037985. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*